BIOEMTECH & NorthStar strike deal to boost access to critical Actinium-225 for preclinical research
The agreement ensures BIOEMTECH customers can consistently obtain Ac-225 for preclinical studies
The agreement ensures BIOEMTECH customers can consistently obtain Ac-225 for preclinical studies
ANYRA is India’s first indigenously developed Aflibercept 2 mg biosimilar
The approval is based on the SWIFT and ANCHOR phase III trials, which demonstrated sustained efficacy with a twice-yearly dosing regimen
The VELO system supports multiplex testing for Influenza A, Influenza B, and COVID-19, producing PCR results in six to ten minutes
Dr Adams’ lab recently uncovered a novel cellular detoxification pathway driving Cisplatin resistance in NSCLC
This transaction fundamentally strengthens Scinai's CDMO platform
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
The initiative, delivered in collaboration with Accenture, integrates digitally enabled operating models powered by advanced analytics and AI across the company’s procurement, manufacturing, and distribution networks
Subscribe To Our Newsletter & Stay Updated